{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:02Z","timestamp":1791296762131,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004094","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T18:43:38Z","timestamp":1443206618000},"page":"e0004094","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity"],"prefix":"10.1371","volume":"9","author":[{"given":"Andrea","family":"N\u00fchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"De Rycker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Manthri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamon","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Robert","family":"Ioset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"ref1","unstructured":"WHO. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected diseases. WHO Library Cataloguing-in-Publication Data. 2013."},{"issue":"5","key":"ref2","first-page":"417","article-title":"Leishmaniasis. Public health aspects and control","volume":"14","author":"P Desjeux","year":"1996","journal-title":"Clinics in dermatology"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comparative Immunology, Microbiology and Infectious Diseases"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2230.2004.01605.x","article-title":"The psychological impact of cutaneous leishmaniasis","volume":"29","author":"M Yanik","year":"2004","journal-title":"Clinical and experimental dermatology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment. QJM: monthly journal of the","volume":"107","author":"BS McGwire","year":"2014","journal-title":"Association of Physicians"},{"issue":"17","key":"ref6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s40265-013-0133-0","article-title":"Therapeutic options for visceral leishmaniasis","volume":"73","author":"B Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"PD Ready","year":"2014","journal-title":"Clinical epidemiology"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/jm040127p","article-title":"From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"48","author":"BL De Corte","year":"2005","journal-title":"Journal of medicinal chemistry"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cbpa.2011.06.007","article-title":"Anti-infectives: can cellular screening deliver?","volume":"15","author":"TH Keller","year":"2011","journal-title":"Current opinion in chemical biology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.41.4.818","article-title":"An axenic amastigote system for drug screening","volume":"41","author":"HL Callahan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-9292-5-6","article-title":"<italic>Leishmania<\/italic> amastigotes as targets for drug screening","volume":"5","author":"A Monte-Alegre","year":"2006","journal-title":"Kinetoplastid Biol Dis"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.mimet.2008.05.026","article-title":"Rapid fluorescent assay for screening drugs on <italic>Leishmania<\/italic> amastigotes","volume":"75","author":"O Shimony","year":"2008","journal-title":"J Microbiol Methods"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpara.2003.10.011","article-title":"Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics","volume":"34","author":"A Debrabant","year":"2004","journal-title":"International Journal for Parasitology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.molbiopara.2005.12.009","article-title":"Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in <italic>Leishmania mexicana<\/italic>","volume":"146","author":"TR Holzer","year":"2006","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00436-008-1048-7","article-title":"Comparison of the expression profiles of promastigotes and axenic amastigotes in <italic>Leishmania donovani<\/italic> using serial analysis of gene expression","volume":"103","author":"Q Li","year":"2008","journal-title":"Parasitol Res"},{"key":"ref16","article-title":"Quantitative proteome profiling informs on phenotypic traits that adapt <italic>Leishmania donovani<\/italic> for axenic and intracellular proliferation","author":"P Pescher","year":"2011","journal-title":"Cell Microbiol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of <italic>Leishmania donovani<\/italic> promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"M Vermeersch","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/AAC.02398-12","article-title":"Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay","volume":"57","author":"M De Rycker","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","article-title":"A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue","volume":"48","author":"J Mikus","year":"2000","journal-title":"Parasitology international"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in <italic>Leishmania<\/italic> cell based drug-screening procedures","volume":"56","author":"D Sereno","year":"2007","journal-title":"Parasitology international"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1371\/journal.pntd.0000675","article-title":"Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds","volume":"4","author":"JL Siqueira-Neto","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A Screen against <italic>Leishmania<\/italic> Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit","volume":"5","author":"G De Muylder","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1096\/fj.07-9254com","article-title":"Retooling Leishmania metabolism: from sand fly gut to human macrophage","volume":"22","author":"D Rosenzweig","year":"2008","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","article-title":"Life in vacuoles\u2014nutrient acquisition by Leishmania amastigotes","volume":"31","author":"RJ Burchmore","year":"2001","journal-title":"International journal for parasitology"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"e1932","DOI":"10.1371\/journal.pntd.0001932","article-title":"A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes","volume":"6","author":"M De Rycker","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nchembio.479","article-title":"Grand challenge commentary: Accessing new chemical space for &apos;undruggable&apos; targets","volume":"6","author":"S Dandapani","year":"2010","journal-title":"Nature chemical biology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"R Brenk","year":"2008","journal-title":"ChemMedChem"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1021\/jo300974j","article-title":"Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries","volume":"77","author":"JT Lowe","year":"2012","journal-title":"The Journal of organic chemistry"},{"issue":"47","key":"ref29","doi-asserted-by":"crossref","first-page":"16962","DOI":"10.1021\/ja105119r","article-title":"An aldol-based build\/couple\/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors","volume":"132","author":"LA Marcaurelle","year":"2010","journal-title":"Journal of the American Chemical Society"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"F Lovering","year":"2009","journal-title":"Journal of medicinal chemistry"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/AAC.00722-13","article-title":"The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral Leishmaniasis","volume":"57","author":"S Patterson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","unstructured":"DNDi. DNDi R&amp;D Projects. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwdndiorg\/diseases-projects\/portfoliohtml\" xlink:type=\"simple\">http:\/\/wwwdndiorg\/diseases-projects\/portfoliohtml<\/ext-link>."},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1021\/jm010283l","article-title":"Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis","volume":"44","author":"KJ Duffy","year":"2001","journal-title":"Journal of medicinal chemistry"},{"issue":"5005","key":"ref34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1850553","article-title":"OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist","volume":"252","author":"Y Yamamura","year":"1991","journal-title":"Science"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections","volume":"141","author":"R Don","year":"2014","journal-title":"Parasitology"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1371\/journal.pntd.0001671","article-title":"An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular <italic>Leishmania donovani<\/italic> Amastigotes in Human Macrophages","volume":"6","author":"JL Siqueira-Neto","year":"2012","journal-title":"Plos Neglect Trop D"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002154","article-title":"High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery","volume":"7","author":"N Aulner","year":"2013","journal-title":"Plos Neglect Trop D"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/AAC.43.2.278","article-title":"Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes","volume":"43","author":"M Ephros","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)36494-8","article-title":"Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design","volume":"280","author":"DJ Naisbitt","year":"1997","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"33","key":"ref40","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","volume":"281","author":"FJ Perez-Victoria","year":"2006","journal-title":"The Journal of biological chemistry"},{"issue":"50","key":"ref41","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"FJ Perez-Victoria","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0022-3565(25)31008-6","article-title":"The rapid reduction of disulfiram in blood and plasma","volume":"202","author":"J Cobby","year":"1977","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jac\/dku422","article-title":"Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis","volume":"70","author":"S Gupta","year":"2015","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejps.2014.09.006","article-title":"In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis","volume":"65","author":"R Mukkavilli","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10822-013-9641-y","article-title":"An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse libraries","volume":"27","author":"CA Mulrooney","year":"2013","journal-title":"Journal of computer-aided molecular design"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:21:47Z","timestamp":1748636507000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004094"}},"subtitle":[],"editor":[{"given":"Gerald F.","family":"Sp\u00e4th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004094","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}